{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:03:31Z","timestamp":1784786611809,"version":"3.55.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101096329"],"award-info":[{"award-number":["101096329"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40258-026-01049-z","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:06:05Z","timestamp":1780052765000},"page":"671-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Health Economic Evaluations of Breast Cancer Screening Strategies: A Systematic Review Focusing on Methodology and Quality Assessment"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6932-3930","authenticated-orcid":false,"given":"Thi Hao","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"de Braak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoukje","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudewi Mukaromah","family":"Khoirunnisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Pfob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrham","family":"Wondimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurjen","family":"van der Schans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette D. I.","family":"van Asselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"1049_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1049_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"1049_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00432-025-06122-z","volume":"151","author":"J Shi","year":"2025","unstructured":"Shi J, Li J, Gao Y, Chen W, Zhao L, Li N, et al. The screening value of mammography for breast cancer: an overview of 28 systematic reviews with evidence mapping. J Cancer Res Clin Oncol. 2025;151:102. https:\/\/doi.org\/10.1007\/s00432-025-06122-z.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1049_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1470-2045(22)00194-2","volume":"23","author":"W Heindel","year":"2022","unstructured":"Heindel W, Weigel S, Ger\u00df J, Hense H-W, Sommer A, Krischke M, et al. Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial. Lancet Oncol. 2022;23:601\u201311. https:\/\/doi.org\/10.1016\/S1470-2045(22)00194-2.","journal-title":"Lancet Oncol"},{"key":"1049_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1200\/GO.20.00168","volume":"6","author":"ST Kakileti","year":"2020","unstructured":"Kakileti ST, Madhu HJ, Krishnan L, Manjunath G, Sampangi S, Ramprakash HV. Observational study to evaluate the clinical efficacy of Thermalytix for detecting breast cancer in symptomatic and asymptomatic women. JCO Glob Oncol. 2020;6:1472\u201380. https:\/\/doi.org\/10.1200\/GO.20.00168.","journal-title":"JCO Glob Oncol"},{"key":"1049_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejca.2018.08.029","volume":"104","author":"AS Tagliafico","year":"2018","unstructured":"Tagliafico AS, Mariscotti G, Valdora F, Durando M, Nori J, La Forgia D, et al. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2). Eur J Cancer. 2018;104:39\u201346. https:\/\/doi.org\/10.1016\/j.ejca.2018.08.029.","journal-title":"Eur J Cancer"},{"key":"1049_CR7","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","volume":"381","author":"MF Bakker","year":"2019","unstructured":"Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med. 2019;381:2091\u2013102. https:\/\/doi.org\/10.1056\/NEJMoa1903986.","journal-title":"N Engl J Med"},{"key":"1049_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1766","volume":"342","author":"S Petrou","year":"2011","unstructured":"Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011;342:d1766. https:\/\/doi.org\/10.1136\/bmj.d1766.","journal-title":"BMJ"},{"key":"1049_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12911-021-01713-5","volume":"21","author":"A Bespalov","year":"2021","unstructured":"Bespalov A, Barchuk A, Auvinen A, Nevalainen J. Cancer screening simulation models: a state of the art review. BMC Med Inform Decis Mak. 2021;21:359.","journal-title":"BMC Med Inform Decis Mak"},{"key":"1049_CR10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s12325-023-02450-z","volume":"40","author":"J Jiang","year":"2023","unstructured":"Jiang J, Jiang S, Ahumada-Canale A, Chen Z, Si L, Jiang Y, et al. Breast cancer screening should embrace precision medicine: evidence by reviewing economic evaluations in China. Adv Ther. 2023;40:1393\u2013417. https:\/\/doi.org\/10.1007\/s12325-023-02450-z.","journal-title":"Adv Ther"},{"key":"1049_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2766-2","volume":"17","author":"M Arnold","year":"2017","unstructured":"Arnold M. Simulation modeling for stratified breast cancer screening - a systematic review of cost and quality of life assumptions. BMC Health Serv Res. 2017;17:802. https:\/\/doi.org\/10.1186\/s12913-017-2766-2.","journal-title":"BMC Health Serv Res"},{"key":"1049_CR12","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.04048","volume":"12","author":"AV Icanervilia","year":"2022","unstructured":"Icanervilia AV, van der Schans J, Cao Q, de Carvalho AC, Cordova-Pozo K, At Thobari J, et al. Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: a systematic review. J Glob Health. 2022;12:04048. https:\/\/doi.org\/10.7189\/jogh.12.04048.","journal-title":"J Glob Health"},{"key":"1049_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1200\/JCO.19.01525","volume":"38","author":"J Jayasekera","year":"2020","unstructured":"Jayasekera J, Mandelblatt JS. Systematic review of the cost effectiveness of breast cancer prevention, screening, and treatment interventions. J Clin Oncol. 2020;38:332\u201350. https:\/\/doi.org\/10.1200\/JCO.19.01525.","journal-title":"J Clin Oncol"},{"key":"1049_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33593","author":"SA Khan","year":"2021","unstructured":"Khan SA, Hernandez-Villafuerte KV, Muchadeyi MT, Schlander M. Cost-effectiveness of risk-based breast cancer screening: a systematic review. Int J Cancer. 2021. https:\/\/doi.org\/10.1002\/ijc.33593.","journal-title":"Int J Cancer"},{"key":"1049_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jval.2020.09.016","volume":"24","author":"A Koldehoff","year":"2021","unstructured":"Koldehoff A, Danner M, Civello D, Rhiem K, Stock S, M\u00fcller D. Cost-effectiveness of targeted genetic testing for breast and ovarian cancer: a systematic review. Value Health. 2021;24:303\u201312. https:\/\/doi.org\/10.1016\/j.jval.2020.09.016.","journal-title":"Value Health"},{"key":"1049_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.breast.2015.03.013","volume":"24","author":"RG Koleva-Kolarova","year":"2015","unstructured":"Koleva-Kolarova RG, Zhan Z, Greuter MJW, Feenstra TL, De Bock GH. Simulation models in population breast cancer screening: a systematic review. Breast. 2015;24:354\u201363. https:\/\/doi.org\/10.1016\/j.breast.2015.03.013.","journal-title":"Breast"},{"key":"1049_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.763161","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Jia Z, Zhang M, Liu G, Xing Z, Wang X, et al. Cost-effectiveness analysis of imaging modalities for breast cancer surveillance among BRCA1\/2 mutation carriers: a systematic review. Front Oncol. 2021;11:763161. https:\/\/doi.org\/10.3389\/fonc.2021.763161.","journal-title":"Front Oncol"},{"key":"1049_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10198-021-01338-5","volume":"22","author":"N M\u00fchlberger","year":"2021","unstructured":"M\u00fchlberger N, Sroczynski G, Gogollari A, Jahn B, Pashayan N, Steyerberg E, et al. Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies. Eur J Health Econ. 2021;22:1311\u201344. https:\/\/doi.org\/10.1007\/s10198-021-01338-5.","journal-title":"Eur J Health Econ"},{"key":"1049_CR19","first-page":"347","volume":"42","author":"A Rashidian","year":"2013","unstructured":"Rashidian A, Barfar E, Hosseini H, Nosratnejad S, Barooti E. Cost effectiveness of breast cancer screening using mammography; a systematic review. Iran J Public Health. 2013;42:347\u201357.","journal-title":"Iran J Public Health"},{"key":"1049_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40258-017-0312-3","volume":"15","author":"IC Schiller-Fr\u00fchwirth","year":"2017","unstructured":"Schiller-Fr\u00fchwirth IC, Jahn B, Arvandi M, Siebert U. Cost-effectiveness models in breast cancer screening in the general population: a systematic review. Appl Health Econ Health Policy. 2017;15:333\u201351. https:\/\/doi.org\/10.1007\/s40258-017-0312-3.","journal-title":"Appl Health Econ Health Policy"},{"key":"1049_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vhri.2023.01.006","volume":"35","author":"SW Yeong","year":"2023","unstructured":"Yeong SW, Lee SW, Ong SC. Cost-effectiveness of breast cancer early detection program in low- and middle-income countries: a systematic review. Value Health Reg Issues. 2023;35:57\u201368. https:\/\/doi.org\/10.1016\/j.vhri.2023.01.006.","journal-title":"Value Health Reg Issues"},{"key":"1049_CR22","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.7314\/apjcp.2013.14.7.4141","volume":"14","author":"K-B Yoo","year":"2013","unstructured":"Yoo K-B, Kwon JA, Cho E, Kang M-H, Nam J-M, Choi K-S, et al. Is mammography for breast cancer screening cost-effective in both Western and Asian countries?: results of a systematic review. Asian Pac J Cancer Prev. 2013;14:4141\u20139. https:\/\/doi.org\/10.7314\/apjcp.2013.14.7.4141.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1049_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.vhri.2020.01.003","volume":"21","author":"P Yuniar","year":"2020","unstructured":"Yuniar P, Robinson S, Moorin R, Norman R. Economic evaluation of breast cancer early detection strategies in Asia: a systematic review. Value Health Reg Issues. 2020;21:252\u201363. https:\/\/doi.org\/10.1016\/j.vhri.2020.01.003.","journal-title":"Value Health Reg Issues"},{"key":"1049_CR24","unstructured":"Pham TH, De Jong L, van der Werf S, D.I. van Asselt A, Maarten P. An open systematic review on methodology, quality, and results of economic evaluations of breast cancer screening strategies [Internet]. PROSPERO. 2023 [cited 2024 July 4]. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42023423840. Accessed 4 July 2024."},{"key":"1049_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1049_CR26","unstructured":"Pitts | Software for living systematic reviews [Internet]. [cited 2023 Apr 24]. https:\/\/app.pitts.ai\/. Accessed 24 Apr 2023."},{"key":"1049_CR27","unstructured":"DeepL AI Platform: Translation, Voice & Agentic Workflows [Internet]. [cited 2026 Mar 11]. https:\/\/www.deepl.com. Accessed 11 Mar 2026."},{"key":"1049_CR28","unstructured":"World Economic Outlook (April 2024) - Inflation rate, average consumer prices [Internet]. [cited 2024 Aug 12]. https:\/\/www.imf.org\/external\/datamapper\/PCPIPCH@WEO. Accessed 12 Aug 2024."},{"key":"1049_CR29","unstructured":"Federal Reserve Board. Foreign Exchange Rates [Internet]. 2024 [cited 2024 Aug 12]. https:\/\/www.federalreserve.gov\/datadownload\/Download.aspx?rel=H10&series=c5d6e0edf324b2fb28d73bcacafaaa02&lastobs=120&from=&to=&filetype=csv&label=include&layout=seriescolumn&type=package. Accessed 12 Aug 2024."},{"key":"1049_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0969141316630766","volume":"23","author":"J Chubak","year":"2016","unstructured":"Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016;23:179\u201385. https:\/\/doi.org\/10.1177\/0969141316630766.","journal-title":"J Med Screen"},{"key":"1049_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jval.2014.01.003","volume":"17","author":"JJ Caro","year":"2014","unstructured":"Caro JJ, Eddy DM, Kan H, Kaltz C, Patel B, Eldessouki R, et al. Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health. 2014;17:174\u201382. https:\/\/doi.org\/10.1016\/j.jval.2014.01.003.","journal-title":"Value Health"},{"key":"1049_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1017\/S0266462305050324","volume":"21","author":"S Evers","year":"2005","unstructured":"Evers S, Goossens M, de Vet H, van Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria. Int J Technol Assess Health Care. 2005;21:240\u20135.","journal-title":"Int J Technol Assess Health Care"},{"key":"1049_CR33","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.1000438","author":"I Odnoletkova","year":"2014","unstructured":"Odnoletkova I. Cost-effectiveness of therapeutic education to prevent the development and progression of Type 2 Diabetes: systematic review. J Diabetes Metab. 2014. https:\/\/doi.org\/10.4172\/2155-6156.1000438.","journal-title":"J Diabetes Metab"},{"key":"1049_CR34","doi-asserted-by":"crossref","unstructured":"Pham T, van der Werf S, de Braak S, Khoirunnisa S, Pan X, Wondimu A, et al. Health-economic evaluations of breast cancer screening strategies: a systematic review. OSF; 2023 [cited 2026 Apr 29]; https:\/\/osf.io\/v6w9a\/overview. Accessed 29 Apr 2026.","DOI":"10.1007\/s40258-026-01049-z"},{"key":"1049_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.maturitas.2017.12.009","volume":"109","author":"RG Koleva-Kolarova","year":"2018","unstructured":"Koleva-Kolarova RG, Daszczuk AM, De Jonge C, Abu Hantash MK, Zhan ZZ, Postema EJ, et al. A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening. Maturitas. 2018;109:81\u20138. https:\/\/doi.org\/10.1016\/j.maturitas.2017.12.009.","journal-title":"Maturitas"},{"key":"1049_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jval.2018.07.880","volume":"22","author":"Y-C Tina Shih","year":"2019","unstructured":"Tina Shih Y-C, Dong W, Xu Y, Shen Y. Assessing the cost-effectiveness of updated breast cancer screening guidelines for average-risk women. Value Health. 2019;22:185\u201393. https:\/\/doi.org\/10.1016\/j.jval.2018.07.880.","journal-title":"Value Health."},{"key":"1049_CR37","doi-asserted-by":"publisher","unstructured":"Wang J, Greuter MJW, Zheng S, Veldhuizen DWAV, Vermeulen KM, Wang Y, et al. Assessment of the benefits and cost-effectiveness of population-based breast cancer screening in urban china: a model-based analysis. Int J Health Policy Manag. 2021. https:\/\/doi.org\/10.34172\/ijhpm.2021.62.","DOI":"10.34172\/ijhpm.2021.62"},{"key":"1049_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7326\/M14-0692","volume":"162","author":"BL Sprague","year":"2015","unstructured":"Sprague BL, Stout NK, Schechter C, Van Ravesteyn NT, Cevik M, Alagoz O, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015;162:157\u201366. https:\/\/doi.org\/10.7326\/M14-0692.","journal-title":"Ann Intern Med"},{"key":"1049_CR39","doi-asserted-by":"publisher","unstructured":"Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. JNCI J Natl Cancer Inst [Internet]. 2014 [cited 2023 Aug 30];106. https:\/\/doi.org\/10.1093\/jnci\/dju092.","DOI":"10.1093\/jnci\/dju092"},{"key":"1049_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jnci\/djab149","volume":"114","author":"JM Yeh","year":"2022","unstructured":"Yeh JM, Lowry KP, Schechter CB, Diller LR, O\u2019Brien G, Alagoz O, et al. Breast cancer screening among childhood cancer survivors treated without chest radiation: clinical benefits and cost-effectiveness. JNCI J Natl Cancer Inst. 2022;114:235\u201344. https:\/\/doi.org\/10.1093\/jnci\/djab149.","journal-title":"JNCI J Natl Cancer Inst."},{"key":"1049_CR41","doi-asserted-by":"publisher","DOI":"10.17116\/profmed20212403122","volume":"24","author":"TV Gazieva","year":"2021","unstructured":"Gazieva TV, Mikhailov IA, Malkov PG, Suleymanov EA, Frank GA. Cancer screening cost-effectiveness analysis of the Chechen Republic population for erly detection of breast cancer and colorectal cancer. Profilakt Med. 2021;24:22. https:\/\/doi.org\/10.17116\/profmed20212403122.","journal-title":"Profilakt Med"},{"key":"1049_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7326\/M19-3481","volume":"173","author":"JM Yeh","year":"2020","unstructured":"Yeh JM, Lowry KP, Schechter CB, Diller LR, Alagoz O, Armstrong GT, et al. Clinical benefits, harms, and cost-effectiveness of breast cancer screening for survivors of childhood cancer treated with chest radiation: a comparative modeling study. Ann Intern Med. 2020;173:331\u201341. https:\/\/doi.org\/10.7326\/M19-3481.","journal-title":"Ann Intern Med"},{"key":"1049_CR43","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1148\/radiol.14141237","volume":"274","author":"CI Lee","year":"2015","unstructured":"Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson ANA, Miglioretti DL, et al. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology. 2015;274:772\u201380. https:\/\/doi.org\/10.1148\/radiol.14141237.","journal-title":"Radiology"},{"key":"1049_CR44","doi-asserted-by":"publisher","DOI":"10.17116\/profmed20222505152","volume":"25","author":"TV Gazieva","year":"2022","unstructured":"Gazieva TV, Mikhailov IA, Malkov PG, Suleimanov EA, Frank GA. Comparison of cost-effectiveness of breast cancer screening by mammographic and ultrasonic methods in the healthcare system of the Chechen Republic. Profilakt Med. 2022;25:52. https:\/\/doi.org\/10.17116\/profmed20222505152.","journal-title":"Profilakt Med"},{"key":"1049_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12913-021-06396-2","volume":"21","author":"JZY Wong","year":"2021","unstructured":"Wong JZY, Chai JH, Yeoh YS, Mohamed Riza NK, Liu J, Teo Y-Y, et al. Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore. BMC Health Serv Res. 2021;21:379. https:\/\/doi.org\/10.1186\/s12913-021-06396-2.","journal-title":"BMC Health Serv Res"},{"key":"1049_CR46","doi-asserted-by":"publisher","first-page":"f2618","DOI":"10.1136\/bmj.f2618","volume":"346","author":"PDP Pharoah","year":"2013","unstructured":"Pharoah PDP, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N. Cost effectiveness of the NHS breast screening programme: life table model. BMJ. 2013;346:f2618\u2013f2618. https:\/\/doi.org\/10.1136\/bmj.f2618.","journal-title":"BMJ"},{"key":"1049_CR47","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.31557\/APJCP.2019.20.10.3153","volume":"20","author":"I Salikhanov","year":"2019","unstructured":"Salikhanov I, Crape B, Howie P. Cost- effectiveness of mammography screening program in a resource-limited Post-Soviet country of Kazakhstan. Asian Pac J Cancer Prev. 2019;20:3153\u201360. https:\/\/doi.org\/10.31557\/APJCP.2019.20.10.3153.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1049_CR48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12282-012-0423-5","volume":"21","author":"M Sato","year":"2014","unstructured":"Sato M, Kawai M, Nishino Y, Shibuya D, Ohuchi N, Ishibashi T. Cost-effectiveness analysis for breast cancer screening: double reading versus single + CAD reading. Breast Cancer. 2014;21:532\u201341. https:\/\/doi.org\/10.1007\/s12282-012-0423-5.","journal-title":"Breast Cancer"},{"key":"1049_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.vhri.2013.02.004","volume":"2","author":"LH Nguyen","year":"2013","unstructured":"Nguyen LH, Laohasiriwong W, Stewart JF, Wright P, Nguyen YTB, Coyte PC. Cost-effectiveness analysis of a screening program for breast cancer in Vietnam. Value Health Reg Issues. 2013;2:21\u20138. https:\/\/doi.org\/10.1016\/j.vhri.2013.02.004.","journal-title":"Value Health Reg Issues"},{"key":"1049_CR50","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2016.17.2.609","author":"N Zehtab","year":"2016","unstructured":"Zehtab N, Jafari M, Barooni M, Nakhaee N, Goudarzi R, Larry Zadeh MH. Cost-effectiveness analysis of breast cancer screening in rural Iran. Asian Pac J Cancer Prev. 2016. https:\/\/doi.org\/10.7314\/apjcp.2016.17.2.609.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1049_CR51","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1158\/1055-9965.EPI-20-1230","volume":"30","author":"S Chootipongchaivat","year":"2021","unstructured":"Chootipongchaivat S, Wong XY, Ten Haaf K, Hartman M, Tan KB, Van Ravesteyn NT, et al. Cost-effectiveness analysis of breast cancer screening using mammography in Singapore: a modeling study. Cancer Epidemiol Biomark Prev. 2021;30:653\u201360. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1230.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1049_CR52","unstructured":"Mo M, Zheng Y, Liu G, Fang H, Zhang X, Zhai L, et al. Cost-effectiveness analysis of two breast cancer screening modalities in Shanghai, China. Zhonghua Zhong Liu Za Zhi. 2015. p. 944\u201351."},{"key":"1049_CR53","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jamaoncol.2018.1901","volume":"4","author":"N Pashayan","year":"2018","unstructured":"Pashayan N, Morris S, Gilbert FJ, Pharoah PDP. Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model. JAMA Oncol. 2018;4:1504. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1901.","journal-title":"JAMA Oncol"},{"key":"1049_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086858","volume":"9","author":"E Vilaprinyo","year":"2014","unstructured":"Vilaprinyo E, Forn\u00e9 C, Carles M, Sala M, Pla R, Castells X, et al. Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PLoS ONE. 2014;9:e86858. https:\/\/doi.org\/10.1371\/journal.pone.0086858.","journal-title":"PLoS ONE"},{"key":"1049_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jfma.2021.06.013","volume":"121","author":"C-N Lin","year":"2022","unstructured":"Lin C-N, Lee K-T, Chang S-M, Wang J-D. Cost-effectiveness evaluation of mammography screening program in Taiwan: adjusting different distributions of age and calendar year for real world data. J Formos Med Assoc. 2022;121:633\u201342. https:\/\/doi.org\/10.1016\/j.jfma.2021.06.013.","journal-title":"J Formos Med Assoc"},{"key":"1049_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29985-z","volume":"13","author":"J Shi","year":"2023","unstructured":"Shi J, Guan Y, Liang D, Li D, He Y, Liu Y. Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province. Sci Rep. 2023;13:3370. https:\/\/doi.org\/10.1038\/s41598-023-29985-z.","journal-title":"Sci Rep"},{"key":"1049_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.breast.2021.12.004","volume":"61","author":"J Wang","year":"2022","unstructured":"Wang J, Greuter MJW, Vermeulen KM, Brokken FB, Dorrius MD, Lu W, et al. Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program. Breast. 2022;61:58\u201365. https:\/\/doi.org\/10.1016\/j.breast.2021.12.004.","journal-title":"Breast"},{"key":"1049_CR58","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/cncr.27864","volume":"119","author":"JE Cott Chubiz","year":"2013","unstructured":"Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, et al. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers: cost-effectiveness of BRCA screening. Cancer. 2013;119:1266\u201376. https:\/\/doi.org\/10.1002\/cncr.27864.","journal-title":"Cancer"},{"key":"1049_CR59","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/bjc.2014.458","volume":"111","author":"CH Ahern","year":"2014","unstructured":"Ahern CH, Shih Y-CT, Dong W, Parmigiani G, Shen Y. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer. 2014;111:1542\u201351. https:\/\/doi.org\/10.1038\/bjc.2014.458.","journal-title":"Br J Cancer"},{"key":"1049_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/0969141314549758","volume":"21","author":"R Pataky","year":"2014","unstructured":"Pataky R, Ismail Z, Coldman AJ, Elwood M, Gelmon K, Hedden L, et al. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density. J Med Screen. 2014;21:180\u20138. https:\/\/doi.org\/10.1177\/0969141314549758.","journal-title":"J Med Screen"},{"key":"1049_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/ijpvm.IJPVM_611_20","volume":"13","author":"M Askarian","year":"2022","unstructured":"Askarian M, Dianat S, Tahmasebi S, Jafari A, Hatam N. Cost-effectiveness of breast cancer screening in Shiraz, Iran. Int J Prev Med. 2022;13:147. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_611_20.","journal-title":"Int J Prev Med"},{"key":"1049_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10552-019-01178-y","volume":"30","author":"SH Rim","year":"2019","unstructured":"Rim SH, Allaire BT, Ekwueme DU, Miller JW, Subramanian S, Hall IJ, et al. Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control. 2019;30:819\u201326. https:\/\/doi.org\/10.1007\/s10552-019-01178-y.","journal-title":"Cancer Causes Control"},{"key":"1049_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5152\/ejbh.2017.3528","volume":"13","author":"V Ozmen","year":"2017","unstructured":"Ozmen V, Gurdal SO, Cabioglu N, Ozcinar B, Ozaydin AN, Kayhan A, et al. Cost-effectiveness of breast cancer screening in turkey, a developing country: results from Bah\u00e7e\u015fehir mammography screening project. Eur J Breast Health. 2017;13:117\u201322. https:\/\/doi.org\/10.5152\/ejbh.2017.3528.","journal-title":"Eur J Breast Health."},{"key":"1049_CR64","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.breast.2015.03.012","volume":"24","author":"Y Gocgun","year":"2015","unstructured":"Gocgun Y, Banjevic D, Taghipour S, Montgomery N, Harvey BJ, Jardine AKS, et al. Cost-effectiveness of breast cancer screening policies using simulation. Breast. 2015;24:440\u20138. https:\/\/doi.org\/10.1016\/j.breast.2015.03.012.","journal-title":"Breast"},{"key":"1049_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194996","volume":"13","author":"CP Nguyen","year":"2018","unstructured":"Nguyen CP, Adang EMM. Cost-effectiveness of breast cancer screening using mammography in Vietnamese women. PLoS ONE. 2018;13:e0194996. https:\/\/doi.org\/10.1371\/journal.pone.0194996.","journal-title":"PLoS ONE"},{"key":"1049_CR66","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamaoncol.2020.2922","volume":"6","author":"HA Geuzinge","year":"2020","unstructured":"Geuzinge HA, Obdeijn I-M, Rutgers EJT, Saadatmand S, Mann RM, Oosterwijk JC, et al. Cost-effectiveness of breast cancer screening with magnetic resonance imaging for women at familial risk. JAMA Oncol. 2020;6:1381. https:\/\/doi.org\/10.1001\/jamaoncol.2020.2922.","journal-title":"JAMA Oncol"},{"key":"1049_CR67","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12282-022-01398-2","volume":"30","author":"TT Ngan","year":"2023","unstructured":"Ngan TT, Browne S, Goodwin M, Van Minh H, Donnelly M, O\u2019Neill C. Cost-effectiveness of clinical breast examination screening programme among HER2-positive breast cancer patients: a modelling study. Breast Cancer. 2023;30:68\u201376. https:\/\/doi.org\/10.1007\/s12282-022-01398-2.","journal-title":"Breast Cancer"},{"key":"1049_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1148\/radiol.2020192505","volume":"297","author":"VDV Sankatsing","year":"2020","unstructured":"Sankatsing VDV, Juraniec K, Grimm SE, Joore MA, Pijnappel RM, De Koning HJ, et al. Cost-effectiveness of digital breast tomosynthesis in population-based breast cancer screening: a probabilistic sensitivity analysis. Radiology. 2020;297:40\u20138. https:\/\/doi.org\/10.1148\/radiol.2020192505.","journal-title":"Radiology"},{"key":"1049_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061241","volume":"13","author":"F Tollens","year":"2021","unstructured":"Tollens F, Baltzer PAT, Dietzel M, R\u00fcbenthaler J, Froelich MF, Kaiser CG. Cost-effectiveness of digital breast tomosynthesis vs. abbreviated breast MRI for screening women with intermediate risk of breast cancer\u2014how low-cost must MRI be? Cancers. 2021;13:1241. https:\/\/doi.org\/10.3390\/cancers13061241.","journal-title":"Cancers"},{"key":"1049_CR70","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/ijc.29572","volume":"137","author":"VDV Sankatsing","year":"2015","unstructured":"Sankatsing VDV, Heijnsdijk EAM, Van Luijt PA, Van Ravesteyn NT, Fracheboud J, De Koning HJ. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands. Int J Cancer. 2015;137:1990\u20139. https:\/\/doi.org\/10.1002\/ijc.29572.","journal-title":"Int J Cancer"},{"key":"1049_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159806","volume":"11","author":"M Posso","year":"2016","unstructured":"Posso M, Carles M, Ru\u00e9 M, Puig T, Bonfill X. Cost-effectiveness of double reading versus single reading of mammograms in a breast cancer screening programme. PLoS ONE. 2016;11:e0159806. https:\/\/doi.org\/10.1371\/journal.pone.0159806.","journal-title":"PLoS ONE"},{"key":"1049_CR72","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/jnci\/djab119","volume":"113","author":"HA Geuzinge","year":"2021","unstructured":"Geuzinge HA, Bakker MF, Heijnsdijk EAM, Van Ravesteyn NT, Veldhuis WB, Pijnappel RM, et al. Cost-effectiveness of magnetic resonance imaging screening for women with extremely dense breast tissue. JNCI J Natl Cancer Inst. 2021;113:1476\u201383. https:\/\/doi.org\/10.1093\/jnci\/djab119.","journal-title":"JNCI J Natl Cancer Inst."},{"key":"1049_CR73","doi-asserted-by":"publisher","first-page":"E77","DOI":"10.9778\/cmajo.20170106","volume":"6","author":"N Mittmann","year":"2018","unstructured":"Mittmann N, Stout NK, Tosteson ANA, Trentham-Dietz A, Alagoz O, Yaffe MJ. Cost-effectiveness of mammography from a publicly funded health care system perspective. CMAJ Open. 2018;6:E77-86. https:\/\/doi.org\/10.9778\/cmajo.20170106.","journal-title":"CMAJ Open"},{"key":"1049_CR74","first-page":"241","volume":"17","author":"E Barfar","year":"2014","unstructured":"Barfar E, Rashidian A, Hosseini H, Nosratnejad S, Barooti E, Zendehdel K. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women. Arch Iran Med. 2014;17:241\u20135.","journal-title":"Arch Iran Med"},{"key":"1049_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.724543","volume":"11","author":"F Tollens","year":"2021","unstructured":"Tollens F, Baltzer PAT, Dietzel M, Schnitzer ML, Kunz WG, Rink J, et al. Cost-effectiveness of MR-mammography in breast cancer screening of women with extremely dense breasts after two rounds of screening. Front Oncol. 2021;11:724543. https:\/\/doi.org\/10.3389\/fonc.2021.724543.","journal-title":"Front Oncol"},{"key":"1049_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109355","volume":"136","author":"CG Kaiser","year":"2021","unstructured":"Kaiser CG, Dietzel M, Vag T, Froelich MF. Cost-effectiveness of MR-mammography vs. conventional mammography in screening patients at intermediate risk of breast cancer - A model-based economic evaluation. Eur J Radiol. 2021;136:109355. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109355.","journal-title":"Eur J Radiol"},{"key":"1049_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-339","volume":"13","author":"R Pataky","year":"2013","unstructured":"Pataky R, Armstrong L, Chia S, Coldman AJ, Kim-Sing C, McGillivray B, et al. Cost-effectiveness of MRI for breast cancer screening in BRCA1\/2 mutation carriers. BMC Cancer. 2013;13:339. https:\/\/doi.org\/10.1186\/1471-2407-13-339.","journal-title":"BMC Cancer"},{"key":"1049_CR78","unstructured":"Wu F, Mo M, Qin X, Fang H, Zhao G, Liu G, et al. Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai. Chin J Endem. 2017. p. 1665\u201371."},{"key":"1049_CR79","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.17269\/cjph.105.4463","volume":"105","author":"JM Timmers","year":"2014","unstructured":"Timmers JM, Damen JA, Pijnappel RM, Verbeek AL, Den Heeten GJ, Adang EM, et al. Cost-effectiveness of non-invasive assessment in the Dutch breast cancer screening program versus usual care: a randomized controlled trial. Can J Public Health. 2014;105:e342\u20137. https:\/\/doi.org\/10.17269\/cjph.105.4463.","journal-title":"Can J Public Health"},{"key":"1049_CR80","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jcpo.2014.09.001","volume":"2","author":"R Pataky","year":"2014","unstructured":"Pataky R, Phillips N, Peacock S, Coldman AJ. Cost-effectiveness of population-based mammography screening strategies by age range and frequency. J Cancer Policy. 2014;2:97\u2013102. https:\/\/doi.org\/10.1016\/j.jcpo.2014.09.001.","journal-title":"J Cancer Policy"},{"key":"1049_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7326\/M20-8076","volume":"175","author":"JT Schousboe","year":"2022","unstructured":"Schousboe JT, Sprague BL, Abraham L, O\u2019Meara ES, Onega T, Advani S, et al. Cost-effectiveness of screening mammography beyond age 75 years: a cost-effectiveness analysis. Ann Intern Med. 2022;175:11\u20139. https:\/\/doi.org\/10.7326\/M20-8076.","journal-title":"Ann Intern Med"},{"key":"1049_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-021-00696-z","volume":"21","author":"S Kejela","year":"2021","unstructured":"Kejela S. Cost-effectiveness of screening mammography in a low income country: a Markov simulation analysis. BMC Med Imaging. 2021;21:162. https:\/\/doi.org\/10.1186\/s12880-021-00696-z.","journal-title":"BMC Med Imaging"},{"key":"1049_CR83","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/jnci\/djt203","volume":"105","author":"S Saadatmand","year":"2013","unstructured":"Saadatmand S, Tilanus-Linthorst MMA, Rutgers EJT, Hoogerbrugge N, Oosterwijk JC, Tollenaar RAEM, et al. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. JNCI J Natl Cancer Inst. 2013;105:1314\u201321. https:\/\/doi.org\/10.1093\/jnci\/djt203.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1049_CR84","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ijc.30513","volume":"140","author":"PA Van Luijt","year":"2017","unstructured":"Van Luijt PA, Heijnsdijk EAM, De Koning HJ. Cost-effectiveness of the Norwegian breast cancer screening program: Norwegian breast cancer screening program. Int J Cancer. 2017;140:833\u201340. https:\/\/doi.org\/10.1002\/ijc.30513.","journal-title":"Int J Cancer"},{"key":"1049_CR85","doi-asserted-by":"publisher","unstructured":"Haghighat S, Akbari ME, Yavari P, Javanbakht M, Ghaffari S. Cost-effectiveness of three rounds of mammography breast cancer screening in iranian women. Iran J Cancer Prev. 2016. https:\/\/doi.org\/10.17795\/ijcp-5443.","DOI":"10.17795\/ijcp-5443"},{"key":"1049_CR86","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.2214\/AJR.15.14487","volume":"207","author":"VB Kalra","year":"2016","unstructured":"Kalra VB, Wu X, Haas BM, Forman HP, Philpotts LE. Cost-effectiveness of tomosynthesis in annual screening mammography. Am J Roentgenol. 2016;207:1152\u20135. https:\/\/doi.org\/10.2214\/AJR.15.14487.","journal-title":"Am J Roentgenol"},{"key":"1049_CR87","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jnci\/djz037","volume":"112","author":"J Furzer","year":"2020","unstructured":"Furzer J, Tessier L, Hodgson D, Cotton C, Nathan PC, Gupta S, et al. Cost-utility of early breast cancer surveillance in survivors of thoracic radiation-treated adolescent Hodgkin lymphoma. JNCI J Natl Cancer Inst. 2020;112:63\u201370. https:\/\/doi.org\/10.1093\/jnci\/djz037.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1049_CR88","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/ijc.31956","volume":"144","author":"L Sun","year":"2019","unstructured":"Sun L, Sadique Z, dos\u2010Santos\u2010Silva I, Yang L, Legood R. Cost\u2010effectiveness of breast cancer screening programme for women in rural China. Int J Cancer. 2019;144:2596\u2013604. https:\/\/doi.org\/10.1002\/ijc.31956.","journal-title":"Int J Cancer"},{"key":"1049_CR89","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2471\/BLT.18.207944","volume":"96","author":"L Sun","year":"2018","unstructured":"Sun L, Legood R, Sadique Z, dos-Santos-Silva I, Yang L. Cost\u2013effectiveness of risk-based breast cancer screening programme, China. Bull World Health Organ. 2018;96:568\u201377. https:\/\/doi.org\/10.2471\/BLT.18.207944.","journal-title":"Bull World Health Organ"},{"key":"1049_CR90","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s41669-022-00343-5","volume":"6","author":"TA Moger","year":"2022","unstructured":"Moger TA, Holen \u00c5, Hanestad B, Hofvind S. Costs and effects of implementing digital tomosynthesis in a population-based breast cancer screening program: predictions using results from the to-be trial in Norway. PharmacoEconomics Open. 2022;6:495\u2013507. https:\/\/doi.org\/10.1007\/s41669-022-00343-5.","journal-title":"PharmacoEconomics Open"},{"key":"1049_CR91","doi-asserted-by":"publisher","first-page":"s131","DOI":"10.1590\/0102-311X00005213","volume":"29","author":"RA Ribeiro","year":"2013","unstructured":"Ribeiro RA, Caleffi M, Polanczyk CA. Custo-efetividade de um programa de rastreamento organizado de c\u00e2ncer de mama no Sul do Brasil. Cad Sa\u00fade P\u00fablica. 2013;29:s131\u201345. https:\/\/doi.org\/10.1590\/0102-311X00005213.","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"1049_CR92","unstructured":"Movik E, Dalsb\u00f8 TK, Fagelund BC, Friberg EG, H\u00e5heim LL, Sk\u00e5r \u00c5. Digital breast tomosynthesis with hologic 3D mammography selenia dimensions system for use in breast cancer screening: a single technology assessment."},{"key":"1049_CR93","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2214\/AJR.16.16987","volume":"208","author":"SA Hunter","year":"2017","unstructured":"Hunter SA, Morris C, Nelson K, Snyder BJ, Poulton TB. Digital breast tomosynthesis: cost-effectiveness of using private and medicare insurance in community-based health care facilities. Am J Roentgenol. 2017;208:1171\u20135. https:\/\/doi.org\/10.2214\/AJR.16.16987.","journal-title":"Am J Roentgenol"},{"key":"1049_CR94","doi-asserted-by":"publisher","unstructured":"Davidovi\u0107 M, Zielonke N, Lansdorp-Vogelaar I, Segnan N, De Koning HJ, Heijnsdijk EAm. Disability-adjusted life years averted versus quality-adjusted life years gained: a model analysis for breast cancer screening. Value Health. 2021;24:353\u201360. https:\/\/doi.org\/10.1016\/j.jval.2020.10.018.","DOI":"10.1016\/j.jval.2020.10.018"},{"key":"1049_CR95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1017\/S0266462315000598","volume":"31","author":"T Bessen","year":"2015","unstructured":"Bessen T, Keefe DMK, Karnon J. Does one size fit all? Cost utility analyses of alternative mammographic follow-up schedules, by risk of recurrence. Int J Technol Assess Health Care. 2015;31:281\u20138. https:\/\/doi.org\/10.1017\/S0266462315000598.","journal-title":"Int J Technol Assess Health Care"},{"key":"1049_CR96","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1007\/s00330-015-4175-4","volume":"26","author":"MC Posso","year":"2016","unstructured":"Posso MC, Puig T, Quintana MJ, Sol\u00e0-Roca J, Bonfill X. Double versus single reading of mammograms in a breast cancer screening programme: a cost-consequence analysis. Eur Radiol. 2016;26:3262\u201371. https:\/\/doi.org\/10.1007\/s00330-015-4175-4.","journal-title":"Eur Radiol"},{"key":"1049_CR97","doi-asserted-by":"publisher","unstructured":"Szynglarewicz B, Matkowski R. Ductal carcinomas in situ and invasive cancers detected on screening mammography: cost-effectiveness of initial and subsequent rounds of population-based program 2007\u20132014. Adv Clin Exp Med. 2017;26:259\u201362. https:\/\/doi.org\/10.17219\/acem\/61841.","DOI":"10.17219\/acem\/61841"},{"key":"1049_CR98","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/BCTT.S123558","volume":"9","author":"R Morton","year":"2017","unstructured":"Morton R, Sayma M, Sura M. Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained? Breast Cancer Targets Ther. 2017;9:217\u201325. https:\/\/doi.org\/10.2147\/BCTT.S123558.","journal-title":"Breast Cancer Targets Ther"},{"key":"1049_CR99","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/13696998.2023.2222035","volume":"26","author":"M Blankenburg","year":"2023","unstructured":"Blankenburg M, S\u00e1nchez-Collado I, Soyemi BO, \u00c5kerborg \u00d6, Caleyachetty A, Harris J, et al. Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare. J Med Econ. 2023;26:850\u201361. https:\/\/doi.org\/10.1080\/13696998.2023.2222035.","journal-title":"J Med Econ"},{"key":"1049_CR100","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12885-016-2386-y","volume":"16","author":"A Arrospide","year":"2016","unstructured":"Arrospide A, Rue M, Van Ravesteyn NT, Comas M, Soto-Gordoa M, Sarriugarte G, et al. Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis. BMC Cancer. 2016;16:344. https:\/\/doi.org\/10.1186\/s12885-016-2386-y.","journal-title":"BMC Cancer"},{"key":"1049_CR101","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1007\/s00330-022-08777-5","volume":"32","author":"F Tollens","year":"2022","unstructured":"Tollens F, Baltzer PAT, Dietzel M, Schnitzer ML, Schwarze V, Kunz WG, et al. Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer. Eur Radiol. 2022;32:7409\u201319. https:\/\/doi.org\/10.1007\/s00330-022-08777-5.","journal-title":"Eur Radiol"},{"key":"1049_CR102","doi-asserted-by":"crossref","unstructured":"Ulloa-P\u00e9rez E, Mohar-Betancourt A, Reynoso-Nover\u00f3n N. Estimation of the cost-effectiveness of breast cancer screening using mammography in Mexico through a simulation. Rev. Investig. Clin. Organo Hosp. Enfermedades Nutr. 2016. p. 184\u201391.","DOI":"10.1016\/S0034-8376(25)00275-X"},{"key":"1049_CR103","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jval.2017.04.012","volume":"20","author":"E Gray","year":"2017","unstructured":"Gray E, Donten A, Karssemeijer N, Van Gils C, Evans DG, Astley S, et al. Evaluation of a stratified national breast screening program in the United Kingdom: an early model-based cost-effectiveness analysis. Value Health. 2017;20:1100\u20139. https:\/\/doi.org\/10.1016\/j.jval.2017.04.012.","journal-title":"Value Health"},{"key":"1049_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.776848","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yang L, Liu S, Li H, Li Q, Cheng Y, et al. Evaluation of different breast cancer screening strategies for high-risk women in Beijing, China: a real-world population-based study. Front Oncol. 2021;11:776848. https:\/\/doi.org\/10.3389\/fonc.2021.776848.","journal-title":"Front Oncol"},{"key":"1049_CR105","doi-asserted-by":"publisher","unstructured":"Duffy S, Mackay J, Thomas S, Anderson E, Chen T, Ellis I, et al. Evaluation of mammographic surveillance services in women aged 40\u201349 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol Assess [Internet]. 2013 [cited 2023 Aug 30];17. https:\/\/doi.org\/10.3310\/hta17110.","DOI":"10.3310\/hta17110"},{"key":"1049_CR106","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijc.34000","volume":"151","author":"LM Kregting","year":"2022","unstructured":"Kregting LM, Sankatsing VDV, Heijnsdijk EAM, De Koning HJ, Van Ravesteyn NT. Finding the optimal mammography screening strategy: a cost\u2010effectiveness analysis of 920 modelled strategies. Int J Cancer. 2022;151:287\u201396. https:\/\/doi.org\/10.1002\/ijc.34000.","journal-title":"Int J Cancer"},{"key":"1049_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287486","volume":"18","author":"N Shafik","year":"2023","unstructured":"Shafik N, Ilmonen P, Viitasaari L, Sarkeala T, Hein\u00e4vaara S. Flexible transition probability model for assessing cost-effectiveness of breast cancer screening extension to include women aged 45\u201349 and 70\u201374. PLoS ONE. 2023;18:e0287486. https:\/\/doi.org\/10.1371\/journal.pone.0287486.","journal-title":"PLoS ONE"},{"key":"1049_CR108","unstructured":"Wong IOL, Tsang JWH, Cowling BJ, Leung GM. Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese. Hong Kong Med. J. 2015. p. S9\u201312."},{"key":"1049_CR109","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1200\/JCO.22.00574","volume":"41","author":"FL Wong","year":"2023","unstructured":"Wong FL, Lee JM, Leisenring WM, Neglia JP, Howell RM, Smith SA, et al. Health benefits and cost-effectiveness of Children\u2019s Oncology Group breast cancer screening guidelines for chest-irradiated Hodgkin Lymphoma survivors. J Clin Oncol. 2023;41:1046\u201358. https:\/\/doi.org\/10.1200\/JCO.22.00574.","journal-title":"J Clin Oncol"},{"key":"1049_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109576","volume":"137","author":"CG Kaiser","year":"2021","unstructured":"Kaiser CG, Dietzel M, Vag T, R\u00fcbenthaler J, Froelich MF, Tollens F. Impact of specificity on cost-effectiveness of screening women at high risk of breast cancer with magnetic resonance imaging, mammography and ultrasound. Eur J Radiol. 2021;137:109576. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109576.","journal-title":"Eur J Radiol"},{"key":"1049_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/pgfar04110","volume":"4","author":"DG Evans","year":"2016","unstructured":"Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, et al. Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Programme Grants Appl Res. 2016;4:1\u2013210. https:\/\/doi.org\/10.3310\/pgfar04110.","journal-title":"Programme Grants Appl Res"},{"key":"1049_CR112","doi-asserted-by":"publisher","unstructured":"Shih Y-CT, Dong W, Xu Y, Etzioni R, Shen Y. Incorporating baseline breast density when screening women at average risk for breast cancer: a cost-effectiveness analysis. Ann Intern Med. 2021;174:602\u201312. https:\/\/doi.org\/10.7326\/M20-2912.","DOI":"10.7326\/M20-2912"},{"key":"1049_CR113","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2214\/AJR.17.18484","volume":"210","author":"KJ Carter","year":"2018","unstructured":"Carter KJ, Castro F, Morcos RN. Insights into breast cancer screening: a computer simulation of two contemporary screening strategies. Am J Roentgenol. 2018;210:564\u201371. https:\/\/doi.org\/10.2214\/AJR.17.18484.","journal-title":"Am J Roentgenol"},{"key":"1049_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-366","volume":"2","author":"FH Souza","year":"2013","unstructured":"Souza FH, Polanczyk CA. Is age-targeted full-field digital mammography screening cost-effective in emerging countries? A micro simulation model. Springerplus. 2013;2:366. https:\/\/doi.org\/10.1186\/2193-1801-2-366.","journal-title":"Springerplus"},{"key":"1049_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217213","volume":"14","author":"M Arnold","year":"2019","unstructured":"Arnold M, Pfeifer K, Quante AS. Is risk-stratified breast cancer screening economically efficient in Germany? PLoS ONE. 2019;14:e0217213. https:\/\/doi.org\/10.1371\/journal.pone.0217213.","journal-title":"PLoS ONE"},{"key":"1049_CR116","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/jnci\/djz184","volume":"112","author":"KP Lowry","year":"2020","unstructured":"Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, et al. Long-term outcomes and cost-effectiveness of breast cancer screening with digital breast tomosynthesis in the United States. JNCI J Natl Cancer Inst. 2020;112:582\u20139. https:\/\/doi.org\/10.1093\/jnci\/djz184.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1049_CR117","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejca.2016.05.012","volume":"63","author":"I-M Obdeijn","year":"2016","unstructured":"Obdeijn I-M, Heijnsdijk EAM, Hunink MGM, Tilanus-Linthorst MMA, De Koning HJ. Mammographic screening in BRCA1 mutation carriers postponed until age 40: evaluation of benefits, costs and radiation risks using models. Eur J Cancer. 2016;63:135\u201342. https:\/\/doi.org\/10.1016\/j.ejca.2016.05.012.","journal-title":"Eur J Cancer"},{"key":"1049_CR118","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jval.2015.06.006","volume":"19","author":"R Rafia","year":"2016","unstructured":"Rafia R, Brennan A, Madan J, Collins K, Reed MWR, Lawrence G, et al. Modeling the cost-effectiveness of alternative upper age limits for breast cancer screening in England and Wales. Value Health. 2016;19:404\u201312. https:\/\/doi.org\/10.1016\/j.jval.2015.06.006.","journal-title":"Value Health"},{"key":"1049_CR119","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jval.2017.12.022","volume":"21","author":"M Arnold","year":"2018","unstructured":"Arnold M, Quante AS. Personalized mammography screening and screening adherence\u2014a simulation and economic evaluation. Value Health. 2018;21:799\u2013808. https:\/\/doi.org\/10.1016\/j.jval.2017.12.022.","journal-title":"Value Health"},{"key":"1049_CR120","unstructured":"Xu J, Wang Q, Ma HM, Xia JH. Primary efficacy of physical examination combined with ultragraphy and complemented with mammography for breast cancer screening. Chin. J. Cancer Prev. Treat. 2013. p. 1295\u20139."},{"key":"1049_CR121","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jval.2013.06.013","volume":"16","author":"J Melnikow","year":"2013","unstructured":"Melnikow J, Tancredi DJ, Yang Z, Ritley D, Jiang Y, Slee C, et al. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program. Value Health. 2013;16:932\u201341. https:\/\/doi.org\/10.1016\/j.jval.2013.06.013.","journal-title":"Value Health"},{"key":"1049_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4168-1","volume":"18","author":"L Yang","year":"2018","unstructured":"Yang L, Wang J, Cheng J, Wang Y, Lu W. Quality assurance target for community-based breast cancer screening in China: a model simulation. BMC Cancer. 2018;18:261. https:\/\/doi.org\/10.1186\/s12885-018-4168-1.","journal-title":"BMC Cancer"},{"key":"1049_CR123","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1002\/ijc.33126","volume":"147","author":"VDV Sankatsing","year":"2020","unstructured":"Sankatsing VDV, Ravesteyn NT, Heijnsdijk EAM, Broeders MJM, Koning HJ. Risk stratification in breast cancer screening: cost\u2010effectiveness and harm\u2010benefit ratios for low\u2010risk and high\u2010risk women. Int J Cancer. 2020;147:3059\u201367. https:\/\/doi.org\/10.1002\/ijc.33126.","journal-title":"Int J Cancer"},{"key":"1049_CR124","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.breast.2019.03.004","volume":"45","author":"X-A Phi","year":"2019","unstructured":"Phi X-A, Greuter MJW, Obdeijn I-M, Oosterwijk JC, Feenstra TL, Houssami N, et al. Should women with a BRCA1\/2 mutation aged 60 and older be offered intensified breast cancer screening?\u2014a cost-effectiveness analysis. Breast. 2019;45:82\u20138. https:\/\/doi.org\/10.1016\/j.breast.2019.03.004.","journal-title":"Breast"},{"key":"1049_CR125","doi-asserted-by":"publisher","DOI":"10.1080\/22423982.2017.1373580","volume":"76","author":"MK Christensen","year":"2017","unstructured":"Christensen MK, Niclasen BV, Iburg KM. Societal costs and effects of implementing population-based mammography screening in Greenland. Int J Circumpolar Health. 2017;76:1373580. https:\/\/doi.org\/10.1080\/22423982.2017.1373580.","journal-title":"Int J Circumpolar Health"},{"key":"1049_CR126","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0476","volume":"165","author":"A Trentham-Dietz","year":"2016","unstructured":"Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, et al. Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes. Ann Intern Med. 2016;165:700. https:\/\/doi.org\/10.7326\/M16-0476.","journal-title":"Ann Intern Med"},{"key":"1049_CR127","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2021-100351","volume":"28","author":"VA Malek Pascha","year":"2021","unstructured":"Malek Pascha VA, Sun L, Gilardino R, Legood R. Telemammography for breast cancer screening: a cost-effective approach in Argentina. BMJ Health Care Inform. 2021;28:e100351. https:\/\/doi.org\/10.1136\/bmjhci-2021-100351.","journal-title":"BMJ Health Care Inform"},{"key":"1049_CR128","doi-asserted-by":"publisher","first-page":"E443","DOI":"10.9778\/cmajo.20200154","volume":"9","author":"S Cressman","year":"2021","unstructured":"Cressman S, Mar C, Sam J, Kan L, Lohrisch C, Spinelli JJ. The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis. CMAJ Open. 2021;9:E443\u201350. https:\/\/doi.org\/10.9778\/cmajo.20200154.","journal-title":"CMAJ Open"},{"key":"1049_CR129","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1007\/s00330-020-06812-x","volume":"30","author":"J Wang","year":"2020","unstructured":"Wang J, Phi X-A, Greuter MJW, Daszczuk AM, Feenstra TL, Pijnappel RM, et al. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program. Eur Radiol. 2020;30:5437\u201345. https:\/\/doi.org\/10.1007\/s00330-020-06812-x.","journal-title":"Eur Radiol"},{"key":"1049_CR130","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jval.2017.04.009","volume":"20","author":"I Schiller-Fruehwirth","year":"2017","unstructured":"Schiller-Fruehwirth I, Jahn B, Einzinger P, Zauner G, Urach C, Siebert U. The long-term effectiveness and cost effectiveness of organized versus opportunistic screening for breast cancer in Austria. Value Health. 2017;20:1048\u201357. https:\/\/doi.org\/10.1016\/j.jval.2017.04.009.","journal-title":"Value Health"},{"key":"1049_CR131","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.7314\/APJCP.2013.14.3.2059","volume":"14","author":"MH Kang","year":"2013","unstructured":"Kang MH, Park E-C, Choi KS, Suh M, Jun JK, Cho E. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective? Asian Pac J Cancer Prev. 2013;14:2059\u201365. https:\/\/doi.org\/10.7314\/APJCP.2013.14.3.2059.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1049_CR132","unstructured":"Mittmann N, Stout NK, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, et al. Total cost-effectiveness of mammography screening strategies. Health Rep. 2015. p. 16\u201325."},{"key":"1049_CR133","doi-asserted-by":"publisher","unstructured":"Leung K, Wu JT, Wong IO, Shu X-O, Zheng W, Wen W, et al. Using risk stratification to optimize mammography screening in Chinese women. JNCI Cancer Spectr. 2021;5:pkab060. https:\/\/doi.org\/10.1093\/jncics\/pkab060.","DOI":"10.1093\/jncics\/pkab060"},{"key":"1049_CR134","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/bjc.2013.149","volume":"108","author":"GH De Bock","year":"2013","unstructured":"De Bock GH, Vermeulen KM, Jansen L, Oosterwijk JC, Siesling S, Dorrius MD, et al. Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness. Br J Cancer. 2013;108:1579\u201386. https:\/\/doi.org\/10.1038\/bjc.2013.149.","journal-title":"Br J Cancer"},{"key":"1049_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003168","volume":"4","author":"S Basu","year":"2024","unstructured":"Basu S, Yudkin JS, Jawad M, Ghattas H, Hamad BA, Jamaluddine Z, et al. Reducing non-communicable diseases among Palestinian populations in Gaza: a participatory comparative and cost-effectiveness modeling assessment. PLoS Glob Public Health. 2024;4:e0003168. https:\/\/doi.org\/10.1371\/journal.pgph.0003168.","journal-title":"PLoS Glob Public Health"},{"key":"1049_CR136","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s44197-024-00239-z","volume":"14","author":"W-S Chung","year":"2024","unstructured":"Chung W-S, Wan TTH, Shiu YT, Shi H-Y. Cost-effectiveness analysis of digital breast tomosynthesis and mammography in breast cancer screening: a Markov modeling study. J Epidemiol Glob Health. 2024;14:933\u201346. https:\/\/doi.org\/10.1007\/s44197-024-00239-z.","journal-title":"J Epidemiol Glob Health"},{"key":"1049_CR137","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-016402","author":"A Chye","year":"2025","unstructured":"Chye A, Jan S, Pathy NB, Luna HGC, Lim SB, Kimman M, et al. Modelling the health, financial protection and equity impacts of upscaling the ACT NOW early intervention breast cancer pilot program in the Philippines: an extended cost-effectiveness analysis. BMJ Glob Health. 2025. https:\/\/doi.org\/10.1136\/bmjgh-2024-016402.","journal-title":"BMJ Glob Health"},{"key":"1049_CR138","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s41669-023-00470-7","volume":"8","author":"HL Couto","year":"2024","unstructured":"Couto HL, Gargano LP, de Oliveira VM, Coelho BA, Pessoa EC, Hassan AT, et al. Cost-effectiveness analysis of digital breast tomosynthesis added to synthetic mammography in breast cancer screening in Brazil. Pharmacoecon Open. 2024;8:403\u201316. https:\/\/doi.org\/10.1007\/s41669-023-00470-7.","journal-title":"Pharmacoecon Open"},{"key":"1049_CR139","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/1754-9485.13664","volume":"68","author":"V Dhurandhar","year":"2024","unstructured":"Dhurandhar V, Bhola N, Chan M, Choi S, Chung T-Y, Giuffre B, et al. Feasibility study comparing synthesized mammography with digital breast tomosynthesis and digital mammography for simulated first round screening in a single BreastScreen NSW centre. J Med Imaging Radiat Oncol. 2024;68:401\u201311. https:\/\/doi.org\/10.1111\/1754-9485.13664.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"1049_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112088","volume":"187","author":"A Fridhammar","year":"2025","unstructured":"Fridhammar A, Johnson K, Rosso A, Andersson E, Andersson I, L\u00e5ng K, et al. Cost effectiveness of digital breast tomosynthesis for breast cancer screening in a Swedish setting. Eur J Radiol. 2025;187:112088. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112088.","journal-title":"Eur J Radiol"},{"key":"1049_CR141","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10552-024-01958-1","volume":"36","author":"I Grady","year":"2025","unstructured":"Grady I, Grady S, Chanisheva N. Adding automated breast ultrasound to mammography in women with increased breast density or at an elevated risk of breast cancer is a cost-effective screening strategy. Cancer Causes Control. 2025;36:473\u201381. https:\/\/doi.org\/10.1007\/s10552-024-01958-1.","journal-title":"Cancer Causes Control"},{"key":"1049_CR142","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/s41416-023-02461-1","volume":"129","author":"H Hill","year":"2023","unstructured":"Hill H, Kearns B, Pashayan N, Roadevin C, Sasieni P, Offman J, et al. The cost-effectiveness of risk-stratified breast cancer screening in the UK. Br J Cancer. 2023;129:1801\u20139. https:\/\/doi.org\/10.1038\/s41416-023-02461-1.","journal-title":"Br J Cancer"},{"key":"1049_CR143","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31715","volume":"7","author":"H Hill","year":"2024","unstructured":"Hill H, Roadevin C, Duffy S, Mandrik O, Brentnall A. Cost-effectiveness of AI for risk-stratified breast cancer screening. JAMA Netw Open. 2024;7:e2431715. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.31715.","journal-title":"JAMA Netw Open"},{"key":"1049_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42820-9","volume":"13","author":"D H\u00f6lzel","year":"2023","unstructured":"H\u00f6lzel D, Halfter K, Schubert-Fritschle G, Engel J. Expanding mammography screening for women aged 40-80 years: evidence from a modeling approach using real-world data. Sci Rep. 2023;13:16229. https:\/\/doi.org\/10.1038\/s41598-023-42820-9.","journal-title":"Sci Rep"},{"key":"1049_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104566","volume":"83","author":"Y-C Hou","year":"2025","unstructured":"Hou Y-C, Lin F-J, Shao Y-HJ. Cost-effectiveness of genetic risk-stratified screening for breast cancer in Taiwan. Breast. 2025;83:104566. https:\/\/doi.org\/10.1016\/j.breast.2025.104566.","journal-title":"Breast"},{"key":"1049_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102894","volume":"77","author":"B Hutchinson","year":"2024","unstructured":"Hutchinson B, Watts R, Nyangasi M, Anderson BO, Chepchumba J, Wangia E, et al. An economic evaluation of breast cancer interventions in Kenya. EClinicalMedicine. 2024;77:102894. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102894.","journal-title":"EClinicalMedicine"},{"key":"1049_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2025.101112","volume":"48","author":"AV Icanervilia","year":"2025","unstructured":"Icanervilia AV, Poelhekken K, At Thobari J, Choridah L, Hutajulu SH, de Bock GH, et al. Cost-effectiveness analysis of mammography-based breast cancer screening in Indonesia. Value Health Reg Issues. 2025;48:101112. https:\/\/doi.org\/10.1016\/j.vhri.2025.101112.","journal-title":"Value Health Reg Issues"},{"key":"1049_CR148","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.vhri.2023.09.002","volume":"39","author":"A Irzaldy","year":"2024","unstructured":"Irzaldy A, Gvamichava R, Beruchashvili T, Sturua L, van Ravesteyn NT, de Koning HJ, et al. Breast cancer screening in georgia: choosing the most optimal and cost-effective strategy. Value Health Reg Issues. 2024;39:66\u201373. https:\/\/doi.org\/10.1016\/j.vhri.2023.09.002.","journal-title":"Value Health Reg Issues."},{"key":"1049_CR149","doi-asserted-by":"publisher","unstructured":"Lin C-N, Lee K-T, Wang J-D, Ku L-JE. Cost-utility evaluation of mammography screening program in Taiwan based on real-world data accounting for false positives. J Formos Med Assoc Taiwan Yi Zhi. 2025;S0929-6646(25)00204-9. https:\/\/doi.org\/10.1016\/j.jfma.2025.04.033.","DOI":"10.1016\/j.jfma.2025.04.033"},{"key":"1049_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-025-03573-x","volume":"25","author":"X Liu","year":"2025","unstructured":"Liu X, Wang Y, Gao B, Lu X, Wang Y, Lu W. Modeling optimal combination of breast and cervical cancer screening strategies in China. BMC Womens Health. 2025;25:56. https:\/\/doi.org\/10.1186\/s12905-025-03573-x.","journal-title":"BMC Womens Health"},{"key":"1049_CR151","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-11821-9","author":"J Lyth","year":"2025","unstructured":"Lyth J, Gialias P, Husberg M, Bernfort L, Bjerner T, Wiberg MK, et al. Results from a Swedish model-based analysis of the cost-effectiveness of AI-assisted digital mammography. Eur Radiol. 2025. https:\/\/doi.org\/10.1007\/s00330-025-11821-9.","journal-title":"Eur Radiol"},{"key":"1049_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2025.101127","volume":"49","author":"SD Masuku","year":"2025","unstructured":"Masuku SD, Mandrik O, Mdege ND, Mishra G, Muwonge R, Meyer-Rath G, et al. Breast cancer screening using clinical breast examination: a cost-effectiveness analysis for South Africa. Value Health Reg Issues. 2025;49:101127. https:\/\/doi.org\/10.1016\/j.vhri.2025.101127.","journal-title":"Value Health Reg Issues"},{"key":"1049_CR153","doi-asserted-by":"publisher","DOI":"10.1177\/09691413251372829","author":"TA Moger","year":"2025","unstructured":"Moger TA, Nardin SB, Holen \u00c5S, Moshina N, Hofvind S. An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway-impact on radiologist person-years, costs and effects. J Med Screen. 2025. https:\/\/doi.org\/10.1177\/09691413251372829.","journal-title":"J Med Screen"},{"key":"1049_CR154","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2024-001356","author":"IJ Nduka","year":"2024","unstructured":"Nduka IJ, Umeh IB, Okafor CV, Orih D, Nduka SO, Ekwunife OI. Cost-benefit analysis of mammography screening: the perspective of Nigerian healthcare providers. BMJ Public Health. 2024. https:\/\/doi.org\/10.1136\/bmjph-2024-001356.","journal-title":"BMJ Public Health"},{"key":"1049_CR155","volume-title":"Supplemental screening as an adjunct to mammography for breast cancer screening in people with dense breasts","author":"Ontario H.","year":"2023","unstructured":"Ontario H. Supplemental screening as an adjunct to mammography for breast cancer screening in people with dense breasts. Canada: Ontario Health; 2023."},{"key":"1049_CR156","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.31557\/APJCP.2024.25.9.3151","volume":"25","author":"F Rahimi","year":"2024","unstructured":"Rahimi F, Tolouei S, Ravankhah Z, Mohammadi-Sefiddashti F. Evaluating the impact of a clinical breast examination screening program within the IraPEN Project. Asian Pac J Cancer Prev. 2024;25:3151\u20137. https:\/\/doi.org\/10.31557\/APJCP.2024.25.9.3151.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1049_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-025-00628-5","author":"F Siegfrids","year":"2025","unstructured":"Siegfrids F, Hein\u00e4vaara S, Sarkeala T, Niinikoski L, Laine J. Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50\u201369 to 45 and\/or 74: a cohort modelling study in the Finnish setting. Health Econ Rev. 2025. https:\/\/doi.org\/10.1186\/s13561-025-00628-5.","journal-title":"Health Econ Rev"},{"key":"1049_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217457","author":"NP Tan","year":"2025","unstructured":"Tan NP, Xia CF, Yan XX, Cao MM, Yang F, He SY, et al. Extending breast cancer screening beyond age 45-64 years in China: a cost-effectiveness analysis. Cancer Lett. 2025. https:\/\/doi.org\/10.1016\/j.canlet.2025.217457.","journal-title":"Cancer Lett"},{"key":"1049_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41754-0","volume":"14","author":"A Vargas-Palacios","year":"2023","unstructured":"Vargas-Palacios A, Sharma N, Sagoo GS. Cost-effectiveness requirements for implementing artificial intelligence technology in the Women\u2019s UK Breast Cancer Screening service. Nat Commun. 2023;14:6110. https:\/\/doi.org\/10.1038\/s41467-023-41754-0.","journal-title":"Nat Commun"},{"key":"1049_CR160","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.52821","volume":"8","author":"AN Wilkinson","year":"2025","unstructured":"Wilkinson AN, Mainprize JG, Yaffe MJ, Robinson J, Cordeiro E, Look Hong NJ, et al. Cost-effectiveness of breast cancer screening using digital mammography in Canada. JAMA Netw Open. 2025;8:e2452821. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.52821.","journal-title":"JAMA Netw Open"},{"key":"1049_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101012","author":"CF Xia","year":"2024","unstructured":"Xia CF, Xu YJ, Li H, He SY, Chen WQ. Benefits and harms of polygenic risk scores in organised cancer screening programmes: a cost-effectiveness analysis. Lancet Reg Health West Pac. 2024. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101012.","journal-title":"Lancet Reg Health West Pac"},{"key":"1049_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20867-1","volume":"25","author":"D Zhou","year":"2025","unstructured":"Zhou D, Zhou K, Wang W, Shao H, Zhang H, Tang W. Comparing the cost-benefit of breast cancer screening programs in rural and urban areas across four economic zones in China: a Markov modeling analysis. BMC Public Health. 2025;25:256. https:\/\/doi.org\/10.1186\/s12889-024-20867-1.","journal-title":"BMC Public Health"},{"key":"1049_CR163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217213","author":"M Arnold","year":"2019","unstructured":"Arnold M, Pfeifer K, Quante A. Is risk-stratified breast cancer screening economically efficient in Germany? PLoS ONE. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0217213.","journal-title":"PLoS ONE"},{"key":"1049_CR164","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","volume":"331","author":"US Preventive Services Task Force","year":"2024","unstructured":"US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331:1918\u201330. https:\/\/doi.org\/10.1001\/jama.2024.5534.","journal-title":"JAMA"},{"key":"1049_CR165","unstructured":"European Commission. European guidelines on breast cancer screening and diagnosis [Internet]. Cancer Screen. Diagn. Care. 2024 [cited 2024 Aug 13]. https:\/\/cancer-screening-and-care.jrc.ec.europa.eu\/en\/ecibc\/european-breast-cancer-guidelines?topic=303&usertype=59&updatef2=0. Accessed 13 Aug 2024."},{"key":"1049_CR166","unstructured":"American Cancer Society Recommendations for the Early Detection of Breast Cancer [Internet]. 2023 [cited 2025 Feb 19]. https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/screening-tests-and-early-detection\/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html. Accessed 19 Feb 2025."},{"key":"1049_CR167","unstructured":"European guidelines on breast cancer screening and diagnosis | European Commission Initiative on Breast and Colorectal cancer [Internet]. 2017 [cited 2025 Feb 19]. https:\/\/cancer-screening-and-care.jrc.ec.europa.eu\/en\/ecibc\/european-breast-cancer-guidelines. Accessed 19 Feb 2025."},{"key":"1049_CR168","unstructured":"WHO position paper on mammography screening [Internet]. Geneva: World Health Organization; 2014 [cited 2025 Feb 19]. https:\/\/www.who.int\/publications\/i\/item\/9789241507936. Accessed 19 Feb 2025."},{"key":"1049_CR169","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1257\/jep.35.2.119","volume":"35","author":"AE Kowalski","year":"2021","unstructured":"Kowalski AE. Mammograms and mortality: how has the evidence evolved. J Econ Perspect. 2021;35:119\u201340. https:\/\/doi.org\/10.1257\/jep.35.2.119.","journal-title":"J Econ Perspect"},{"key":"1049_CR170","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1148\/radiol.2021203633","volume":"299","author":"SGA Veenhuizen","year":"2021","unstructured":"Veenhuizen SGA, de Lange SV, Bakker MF, Pijnappel RM, Mann RM, Monninkhof EM, et al. Supplemental breast MRI for women with extremely dense breasts: results of the second screening round of the DENSE Trial. Radiology. 2021;299:278\u201386. https:\/\/doi.org\/10.1148\/radiol.2021203633.","journal-title":"Radiology"},{"key":"1049_CR171","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.breast.2022.04.003","volume":"64","author":"W Ren","year":"2022","unstructured":"Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: a systematic review. Breast. 2022;64:85\u201399. https:\/\/doi.org\/10.1016\/j.breast.2022.04.003.","journal-title":"Breast"},{"key":"1049_CR172","doi-asserted-by":"publisher","DOI":"10.1093\/acrefore\/9780190625979.013.377","volume-title":"Economic evaluation of medical screening","author":"E Aas","year":"2019","unstructured":"Aas E, Burger E, Pedersen K. Economic evaluation of medical screening. Oxford University Press; 2019. https:\/\/doi.org\/10.1093\/acrefore\/9780190625979.013.377."},{"key":"1049_CR173","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/jncimonographs\/lgac008","volume":"2022","author":"Y-CT Shih","year":"2022","unstructured":"Shih Y-CT, Sabik LM, Stout NK, Halpern MT, Lipscomb J, Ramsey S, et al. Health economics research in cancer screening: research opportunities, challenges, and future directions. JNCI Monogr. 2022;2022:42\u201350. https:\/\/doi.org\/10.1093\/jncimonographs\/lgac008.","journal-title":"JNCI Monogr"},{"key":"1049_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287486","volume":"18","author":"N Shafik","year":"2023","unstructured":"Shafik N, Ilmonen P, Viitasaari L, Sarkeala T, Hein\u00e4vaara S. Flexible transition probability model for assessing cost-effectiveness of breast cancer screening extension to include women aged 45-49 and 70-74. PLoS ONE. 2023;18:e0287486. https:\/\/doi.org\/10.1371\/journal.pone.0287486.","journal-title":"PLoS ONE"},{"key":"1049_CR175","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40273-015-0327-2","volume":"34","author":"P Vemer","year":"2016","unstructured":"Vemer P, Corro Ramos I, van Voorn GAK, Al MJ, Feenstra TL. AdViSHE: a validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics. 2016;34:349\u201361. https:\/\/doi.org\/10.1007\/s40273-015-0327-2.","journal-title":"Pharmacoeconomics"},{"key":"1049_CR176","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.jval.2023.06.014","volume":"26","author":"N Kunst","year":"2023","unstructured":"Kunst N, Siu A, Drummond M, Grimm SE, Grutters J, Husereau D, et al. Consolidated health economic evaluation reporting standards\u2014value of information (CHEERS-VOI): explanation and elaboration. Value Health. 2023;26:1461\u201373. https:\/\/doi.org\/10.1016\/j.jval.2023.06.014.","journal-title":"Value Health"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-026-01049-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:28:29Z","timestamp":1781173709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-026-01049-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":176,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1007\/s40258-026-01049-z","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required, as the study is a systematic review based solely on previously published data and does not involve human participants or primary data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication (from patients\/participants)"}},{"value":"All data supporting the findings of this study are available within the paper and its supplementary materials. Additionally, all supporting data and the pre-processing\/analysis code are available and openly accessible in the OSF repository [\n                      \n                      ]. The repository can be accessed via the following link:","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Code related to data synthesis and the development of the interactive dashboard is openly available in the project\u2019s repository on the Open Science Framework, sections 6. Data analysis and 7. Dashboard [\n                      \n                      ].","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conceptualization: THP, LdJ, AD.IvA, and MJP; Methodology: THP, SvdW, and LdJ; Data curation: THP and SvdW; Investigation (screening, data extraction, and quality assessment): THP, LdJ, SdB, SMK, XP, AW, AP, and AD.IvA; Formal analysis: THP and SdB; Software and interactive platform development: THP; Interpretation of the results: THP, LdJ, AP, JvdS, AD.IvA, and MJP; Writing the original draft: THP and SdB; Reviewing and editing: all authors; Supervision: LdJ, AD.IvA, JvdS, and MJP; Funding acquisition: MJP. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}